Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

MUOTO

Financiado

Commercialization of 3D histopathological evaluation of osteoarthritis new too...

Commercialization of 3D histopathological evaluation of osteoarthritis new tools for therapy monitoring from preclinical testing to hospitals Osteoarthritis (OA) is the most common musculoskeletal disease. OA has significant socio-economic impact as it severely affects the quality of life, reduces productivity and carries higher risk of mortality. However, the developme... ver más

31/12/2021

UOULU

150K€

Presupuesto del proyecto: 150K€

Líder del proyecto

OULUN YLIOPISTO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-12-31

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

ERC-2019-POC: ERC Proof of Concept Grant

I+D

Cerrada hace 5 años

0% 100%

2 Participantes

UOULU

150.00K€ | Lider

GAS GAS

509.95K€ | Participante

Proyectos interesantes

EQC2019-006085-P Equipo de microtomografía para investigación científica, dia... 242K€ Cerrado

MIRACLE Mid infrared arthroscopy innovative imaging system for real... 7M€ Cerrado

PID2021-126469OB-C21 HYBRID REPRESENTATIONS OF OA: FROM BIOLOGY TO PATIENT CHARAC... 156K€ Cerrado

DPI2016-80283-C2-2-R CARACTERIZACION CLINICA, RADIOLOGICA Y ANALITICA DEL PACIENT... 168K€ Cerrado

FRONTIER From Research Optoacoustic Novelty To Imaging Established in... 4M€ Cerrado

IseeG FunctIonal optoacousticS for imaging Early onsEt of Gut infl... 1M€ Cerrado

Últimas noticias

27-11-2024: Videojuegos y creaci... Se abre la línea de ayuda pública: Ayudas para la promoción del sector del videojuego, del pódcast y otras formas de creación digital

27-11-2024: DGIPYME En las últimas 48 horas el Organismo DGIPYME ha otorgado 1 concesiones

27-11-2024: FUNDACION-EOI En las últimas 48 horas el Organismo FUNDACION EOI ha otorgado 2 concesiones

Duración del proyecto: 25 meses Fecha Inicio: 2019-11-18
Fecha Fin: 2021-12-31

Líder del proyecto

OULUN YLIOPISTO

TRL 4-5

Presupuesto del proyecto 150K€

Descripción del proyecto Osteoarthritis (OA) is the most common musculoskeletal disease. OA has significant socio-economic impact as it severely affects the quality of life, reduces productivity and carries higher risk of mortality. However, the development of new treatments for OA is painstakingly long and very challenging. There are many clinical OA drug trials that have ended in a failure. In my ERC-StG project, we have developed 3D histopathological evaluation method of OA from micro-computed tomography (μCT). It allows detecting narrow cracks and surface irregularities that are associated with very early OA. Importantly, with our novel method deterioration and degradation of joint surfaces can be analysed much earlier than with any other non-invasive imaging solution. The key is in pinpointing the most important histological changes with the highest reliability while retaining the anatomical information, lost in the conventional histology. This is expected to decrease the number of histological evaluations by 20-fold, saving substantial amount of time, and consequently, money. We will significantly add value to pharmaceutical industry developing new therapies for OA. Eventually, our solution speeds up the time-to-market for new and more effective OA drugs, while saving in R&D costs. Later on, we can offer inexpensive, effective and accurate diagnosis and prognosis tool for OA patients. Gradually, we will gather a big data repository of various compounds and their effects on OA. From this data, and with the help of Artificial Intelligence engine, we can visually show the predicted compound efficacy, or suggest a drug combination never imagined earlier. In this PoC, the commercialization planning is carried out with a focal point on Software as a Service (SaaS) business model. We will also improve the adoptability of our innovation (e.g. visualisation of the OA severity, positioning in the value chain) and plan the big data business strategy.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores